Filing Details
- Accession Number:
- 0001104659-22-067763
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-02 20:03:59
- Reporting Period:
- 2022-05-31
- Accepted Time:
- 2022-06-02 20:03:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1425205 | Iovance Biotherapeutics Inc. | IOVA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1210317 | A Merrill Mcpeak | C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-31 | 10,000 | $6.84 | 20,150 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-05-31 | 10,000 | $6.80 | 218,633 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By Trust |
Footnotes
- An aggregate of 200,000 shares previously held by the reporting person were transferred as a bona fide gift earlier in 2022.
- These shares are held by a family trust for which the reporting person is a trustee.